Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001240221 | SCV001413147 | uncertain significance | Congenital myasthenic syndrome 4A | 2024-01-22 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 6 of the CHRNE protein (p.Leu6Phe). This variant is present in population databases (rs746521766, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with CHRNE-related conditions. ClinVar contains an entry for this variant (Variation ID: 965708). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CHRNE protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Athena Diagnostics | RCV001664775 | SCV001879840 | uncertain significance | not provided | 2020-09-21 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001664775 | SCV003830630 | uncertain significance | not provided | 2019-06-28 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001834116 | SCV002087540 | uncertain significance | Congenital myasthenic syndrome | 2020-03-13 | no assertion criteria provided | clinical testing |